PPAR-gamma agonist rosiglitazone reverses increased cerebral venous hydraulic conductivity during hypertension.
about
Pharmacological inhibitors of TRPV4 channels reduce cytokine production, restore endothelial function and increase survival in septic miceMegalin/LRP2 expression is induced by peroxisome proliferator-activated receptor -alpha and -gamma: implications for PPARs' roles in renal functionThe cerebral circulation during pregnancy: adapting to preserve normalcy.Plasma from preeclamptic women increases blood-brain barrier permeability: role of vascular endothelial growth factor signaling.Role of peroxisome proliferator-activated receptor-γ in vascular muscle in the cerebral circulation.Differential effects of short-term treatment with two AT1 receptor blockers on diameter of pial arterioles in SHR.Hypothalamic microinflammation: a common basis of metabolic syndrome and aging.Protecting against vascular disease in brainSeizures in Women with Preeclampsia: Mechanisms and Management.Plasma from patients with HELLP syndrome increases blood-brain barrier permeability.Inhibition of protein kinase Cβ reverses increased blood-brain barrier permeability during hyperglycemic stroke and prevents edema formation in vivo.The adaptation of the blood-brain barrier to vascular endothelial growth factor and placental growth factor during pregnancyPregnant serum induces neuroinflammation and seizure activity via TNFα.Increased oxidized low-density lipoprotein causes blood-brain barrier disruption in early-onset preeclampsia through LOX-1Cerebrovascular dysfunction and blood-brain barrier permeability induced by oxidized LDL are prevented by apocynin and magnesium sulfate in female rats.Neural Vascular Mechanism for the Cerebral Blood Flow Autoregulation after Hemorrhagic Stroke.Protective effects of PPAR-γ against pregnancy-induced hypertension by differential ETR expression in rat models.
P2860
Q27345533-DBB4FC21-ECAE-4B16-8E64-0446F5D80B73Q27437610-1076F724-A082-4702-8A64-6EA59EAE4581Q33891503-E4EB62F6-84C5-489F-8929-196B0838C217Q34222231-C6703364-79CE-40BB-8F1F-27BEFAE36D42Q34315697-3A17FE51-6E03-474D-96B0-1E2A3BA56150Q34407931-17C944A8-72CE-4961-BB88-63920B886723Q34808934-6CA9C8AF-E243-4918-A4BC-4C7A6DF44F69Q34979773-7E283C1C-BB35-448F-94F9-827ABAB106A8Q35058409-3629D692-5AAB-49E0-8311-F670CC5B3C57Q35155096-064B9570-1688-4A8C-8156-99E240C1C505Q35449444-AB7DCD97-D6F7-48D5-9836-B9D4C7794309Q35647966-2BF245CD-2F7A-495C-8AED-B1F0D0906E3CQ35830984-24C80EE2-3C7D-4FC4-80FE-9AE273F8B5A8Q36615134-98AB679A-3D3E-452F-BE53-F4EBADCBA9D1Q37541283-C5AD7C18-320E-4736-A08A-0E294D554081Q47124231-91933B33-CDB3-4094-8A3B-4809616F42D7Q47616944-2060289E-F183-4DE8-A7FD-C93F6A5813AB
P2860
PPAR-gamma agonist rosiglitazone reverses increased cerebral venous hydraulic conductivity during hypertension.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 07 August 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
PPAR-gamma agonist rosiglitazo ...... ductivity during hypertension.
@en
PPAR-gamma agonist rosiglitazo ...... ductivity during hypertension.
@nl
type
label
PPAR-gamma agonist rosiglitazo ...... ductivity during hypertension.
@en
PPAR-gamma agonist rosiglitazo ...... ductivity during hypertension.
@nl
prefLabel
PPAR-gamma agonist rosiglitazo ...... ductivity during hypertension.
@en
PPAR-gamma agonist rosiglitazo ...... ductivity during hypertension.
@nl
P2093
P2860
P1476
PPAR-gamma agonist rosiglitazo ...... ductivity during hypertension.
@en
P2093
Abbie C Chapman
Marilyn J Cipolla
Tim J M Roberts
P2860
P304
P356
10.1152/AJPHEART.00630.2009
P577
2009-08-07T00:00:00Z